ERN1 and glioma: This was reinforced by our work on the P336L mutation which is, so far, the only IRE1 mutation identified in more than one tumor sample and even in more than one cancer type [one in glioma (Parsons et al, 2008) and two in intestinal cancers (Cosmic)], thereby confirming its relationship with cancer development.